Filing Details

Accession Number:
0001209191-17-011322
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-16 08:17:31
Reporting Period:
2017-02-14
Filing Date:
2017-02-16
Accepted Time:
2017-02-16 08:17:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595896 James Mandell C/O Bluebird Bio, Inc.
150 Second Street
Cambridge MA 02141
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-14 4,000 $21.43 5,000 No 4 M Direct
Common Stock Acquisiton 2017-02-14 1,950 $25.16 6,950 No 4 M Direct
Common Stock Disposition 2017-02-14 5,950 $80.01 1,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2017-02-14 4,000 $0.00 4,000 $21.43
Common Stock Stock Option (right to buy) Acquisiton 2017-02-14 1,950 $0.00 1,950 $25.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-01-08 No 4 M Direct
5,550 2024-06-11 No 4 M Direct
Footnotes
  1. This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
  2. The range in prices for the transaction reported on this line was $80.00 to $80.15. The average weighted price was $80.0128. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. This option vests ratably over three years in annual installments, commencing on January 8, 2014.
  4. This option vests 100% on the earlier of June 11, 2015 or the date of the next annual meeting of stockholders.